Health & Human Services

Undated vendor help article; describes launch-state limits that may change; does not separately document Claude Meetings retention. Cross-tagged health-human-services (HIPAA-ready exclusion) and k12 (not yet in Claude for Teachers).

Undated; the listing of 5.2 implies a Nov. 9 update but the page shows no revision date. Vendor policy, not an independent audit. Cross-tagged state-government and health-human-services because 30-day retention affects records, CJIS, HIPAA and Medicaid data handling decisions.

Government announcement relayed by state media; no accuracy, usage or time-savings data; vendor and regulator are closely linked.

Summary of testimony, not measured results; no denial-reduction figures are given; the hearing outcome and any HPC action are not reported.

Outcome figures come from city officials, not an independent evaluation; the welfare-uptake gain is unquantified; the attendance gain is a city hall claim; pilot sample was 300 women with no control group.

Vendor-authored summary; SAMA members include vendors who sell to Medicaid agencies; the readiness guide itself was not reviewed here; no state adoption or outcome data.

Symposium coverage by the host university; findings are summarized from talks rather than published papers; the LA work predates this event and is reported without methods detail.

Session reporting, not the ASTHO survey itself; figures are panelists’ summaries of a 2025 survey; the Dallas County uses are described without outcome data.

Trade report from board papers; no pilot outcome metrics, accuracy figures or contract value were given; NHS DTAC and clinical safety roles have no direct U.S. equivalent.

Vendor-authored; most evaluations self-run; HealthBench run by a third party at Anthropic request with no confidence intervals; benchmarks are not public-sector workloads. Cross-tagged health-human-services because the card reports HealthBench results (run by Artificial Analysis) directly relevant to public-health and Medicaid knowledge work.

Local TV report; no performance or safety data on the tools; recommendations are not yet drafted publicly.

Savings figure is an agency claim relayed in a webinar, not an audited attribution to AI; no model accuracy, false-positive or provider-harm data were given; the article does not describe state-level tooling.

Trade article rests on OCHIN/Attuned/Lynn statements; no published conversion, error or disparity metrics yet. Vendor claims about capacity gains are unverified here.

Metrics are agency/vendor-reported; MiCARA false-positive rate not disclosed. Michigan ACLU SNAP AI concerns were previously reported in August; this piece adds multi-state procurement and newer metrics.

No wait-time, accuracy or uptake data were reported despite the headline goal of reducing wait times; based on agency statements to a news outlet.

Expert podcast, not a new peer-reviewed trial; consumer LLM focus rather than a specific agency deployment.

The report does not say how many suppliers applied or passed, which conditions they failed, or whether DHCW will rerun the exercise.

Single local news report; AI is a minor element of the hearing. No measured effects, tool details or independent evaluation.

Canadian local public health; self-reported 91% resolution without published external validation or safety incident rates.

Private academic hospital, not a public agency; relevance to public hospitals is by analogy. Secondary reporting; tool unnamed and controls at Bayview unknown. Practitioner views come from LinkedIn posts and a June webinar.

Non-US, pre-output, and reported by trade press rather than a WHO release reviewed here. Transferability to US public health is limited to evaluation methods.

Federal Medicare WISeR, not Medicaid; documents describe early-2026 problems and CMS asserts current compliance. Choose Nextgov over MedCity/EFF as the Nov. 2 independent-reporting synthesis.

Vendor marketing piece with a sales call to action; figures are unverified and agencies unnamed. Opt-in and help-desk counts are adoption signals, not accuracy or outcome measures.

Reporting relies partly on one family's letter; counts (about 12 plus 4) are as reported. Whether incidents were filed as HIPAA breaches and whether other facilities had similar use is not stated.

Non-US and pre-output; transferability to US state and local public health is limited to agenda-setting. No evidence of effectiveness.

News release, not a peer-reviewed evaluation of BRIDGE accuracy. Lao/Philippines stats predate or sit beside BRIDGE and should not be read as BRIDGE outcomes. International transferability to U.S. SLED is limited by law and platform access.

Nonprofit provider, not a government agency; promotional source with no metrics. Relevance to public agencies is through contracted provider networks.

These are allegations in a single indictment, and the defendant is presumed innocent. The release spells his surname two ways. It does not say what 'Super Intelligence' refers to. Federal agencies also use the term for AI generally, so it may not be a product name. This is one case in one state; it shows a risk, not how often it happens. The evidence class was set to government-audit as the closest available label for a federal enforcement announcement; it is not an audit.

Advocacy source that is party counsel. Interim procedural ruling only. interRAI is a standardized assessment instrument with state-defined scoring; the release does not claim it uses machine learning. Single plaintiff.

Grant announcement, not measured Nava results on Medicaid/SNAP mapping. Mississippi/New Jersey figures are other PBIF projects. Overlaps thematically with the Oct 23 StateScoop PBIF round story archived in state-government; this URL and Nava-specific scope were not in the HHS or checked archive set.